Catheter Precision (VTAK) Shares Outstanding (2017 - 2026)

Catheter Precision (VTAK) has 5 years of Shares Outstanding (Entity) data on file, last reported at $2.0 in Q1 2022.

• On a quarterly basis, Shares Outstanding (Entity) fell 99.42% year-over-year to $2.0 in Q1 2022; TTM through Mar 2022 was $2.0, a 99.42% decrease from a year earlier, with the FY2021 full-year figure at $532.0, up 197.21% from the prior year.
• Shares Outstanding (Entity) for Q1 2022 stood at $2.0, down from $532.0 in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for VTAK reached as high as $741.0 in Q3 2021 and fell as low as $2.0 in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $207.07 across 5 years, with a median of $79.0 in 2020.
• Across the five-year window, Shares Outstanding (Entity) soared 481.36% in 2021 and sank 99.42% in 2022, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $39.0 in 2018, then surged by 48.72% to $58.0 in 2019, then surged by 208.62% to $179.0 in 2020, then soared by 197.21% to $532.0 in 2021, then plunged by 99.62% to $2.0 in 2022.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $2.0 in Q1 2022, $532.0 in Q4 2021, and $741.0 in Q3 2021.